Leber hereditary optic neuropathy: Outlining disease’s natural course

A new gene therapy for this patient population targets the ND4 gene mutation.

As COVID-19 focuses attention on vaccine, medication shortages loom

Amid ramped up production of vaccines, CARES Act gives FDA power to head off potential drug shortfalls. Prevent Blindness is urging the FDA to use its authority to ensure TED treatment drug supply isn’t interrupted.

Managing ocular toxicities in myeloma

Shaily Shah, MD, Northern California Cornea Associates, shares pearls for ophthalmologists on managing ocular toxicities in patients with myeloma.